×
About 35,900 results

ALLMedicine™ Hepatitis B Virus Center

Research & Reviews  17,545 results

Amygdalin promotes the activity of T cells to suppress the progression of HBV-related h...
https://doi.org/10.1186/s12879-020-05713-0
BMC Infectious Diseases; Wang R, Zhang D et. al.

Jan 13th, 2021 - Hepatitis B virus (HBV) infection is a high-risk factor of hepatocellular carcinoma (HCC). Cellular immune responses are essential for HCC development, and the CD4+ and CD8+ T subtypes are identified as the primary anti-tumor immune cells. In the ...

Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patie...
https://doi.org/10.1186/s12985-021-01487-2 10.1007/s00281-012-0327-7 10.1016/j.jhep.2019.03.034 10.1186/s12882-015-0010-z 10.1002/jmv.21121 10.1016/S1473-3099(02)00345-6 10.1111/liv.12324 10.1055/s-0039-1678728 10.3748/wjg.v17.i15.1927 10.1128/CMR.00018-11 10.3349/ymj.2017.58.3.557 10.1016/S2468-1253(18)30002-5 10.1007/s00535-016-1273-2 10.1186/1743-422X-7-324 10.1016/j.jhep.2013.05.043 10.3748/wjg.v21.i42.11931 10.1006/viro.1999.9833 10.1016/S0168-8278(01)00264-1 10.1128/JVI.79.5.3038-3051.2005 10.1111/j.1440-1746.2011.06940.x 10.1016/j.patbio.2009.11.001 10.1111/j.1478-3231.2012.02764.x 10.1159/000329809 10.1038/cddis.2013.219 10.1038/cti.2016.68 10.4049/jimmunol.1103139 10.1016/j.jviromet.2018.03.001 10.1080/10635150600755453 10.1590/S0100-879X2006005000197 10.1590/S0004-28032007000100013 10.1111/hdi.12285 10.1111/j.1440-1746.2009.05972.x 10.1590/S0100-879X2006000400013 10.1111/j.1399-3062.2005.00091.x 10.1016/j.virusres.2017.09.022 10.1053/jhep.2001.28708 10.1016/S0140-6736(05)17961-6 10.3350/kjhep.2008.14.1.67 10.7150/jca.6609 10.1111/j.1478-3231.2011.02481.x 10.3748/wjg.v17.i12.1558 10.1002/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3 10.1002/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2 10.1016/S0168-8278(00)80311-6 10.1016/S0168-8278(00)00100-8 10.1111/j.1572-0241.2000.03371.x 10.1002/jmv.1057 10.1016/j.cyto.2009.06.005 10.1590/S0074-02762011000800018 10.1016/j.humimm.2014.08.198 10.3748/wjg.v12.i3.482 10.1016/j.cyto.2017.04.008 10.1098/rsob.190109 10.1016/j.autrev.2012.05.004 10.1002/hep.23273 10.1111/j.1537-2995.2012.03575.x 10.1111/imm.12720 10.1097/QAD.0000000000000654 10.1016/j.virol.2015.02.026 10.1146/annurev.immunol.17.1.701 10.4238/2014.November.27.2 10.1016/j.jhep.2011.11.011
Virology Journal; Ribeiro CRA, de Almeida NAA et. al.

Jan 13th, 2021 - The hepatitis B virus (HBV) is one of the leading causes of acute, chronic and occult hepatitis (OBI) representing a serious public health threat. Cytokines are known to be important chemical mediators that regulate the differentiation, proliferat...

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosi...
https://doi.org/10.1371/journal.pone.0244939
PloS One; Yen YH, Cheng YF et. al.

Jan 13th, 2021 - A recent study from the United States reported that nearly 12% of hepatocellular carcinomas (HCCs) occurred in patients without cirrhosis. Non-alcoholic fatty liver disease (NAFLD) was the most common liver disease in these patients. We aim to eva...

see more →

Guidelines  47 results

Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
https://ascopubs.org/doi/full/10.1200/JCO.20.01757
Journal of Clinical Oncology; Hwang JP

Jul 26th, 2020 - This Provisional Clinical Opinion update presents a clinically pragmatic approach to hepatitis B virus (HBV) screening and management.

Management of hepatitis B virus infection, updated Swedish guidelines.
https://doi.org/10.1080/23744235.2019.1675903
Infectious Diseases (London, England); Westin J, Aleman S et. al.

Oct 15th, 2019 - Despite access to effective antiviral drugs and vaccines, hepatitis B virus (HBV) infection remains a major health issue worldwide. HBV is highly infectious and may cause chronic infection, progressive liver damage, hepatocellular cancer (HCC) and...

Screening for Hepatitis B Virus Infection in Pregnant Women US Preventive Services Task Force Reaffirmation Recommendation Statement
https://jamanetwork.com/journals/jama/fullarticle/2738558
JAMA

Jul 22nd, 2019 - Screening for hepatitis B virus (HBV) infection during pregnancy identifies women whose infants are at risk of perinatal transmission. Data from a nationally representative sample showed a prevalence of maternal HBV infection of 85.8 cases per 100...

Hepatitis B Screening in Pregnant Women A Perspective on the New USPSTF Recommendations
https://jamanetwork.com/journals/jama/fullarticle/2738527
JAMA

Jul 22nd, 2019 - Contemporary clinicians who provide obstetric care acknowledge screening of pregnant women for perinatally transmissible infectious diseases as a routine component of prenatal care,1 although this has not always been the case. For example, prenata...

Guidelines Insights: Hepatobiliary Cancers, Version 2.2019
https://jnccn.org/view/journals/jnccn/17/4/article-p302.xml
Benson,A.,et al

Mar 31st, 2019 - Incidence and mortality rates for cancer overall are declining, but both incidence and mortality rates for hepatocellular carcinoma (HCC) are increasing.1,2 Risk factors for development of HCC include infection with hepatitis B virus (HBV) and/or ...

see more →

Drugs  19 results see all →

Clinicaltrials.gov  17,895 results

Amygdalin promotes the activity of T cells to suppress the progression of HBV-related h...
https://doi.org/10.1186/s12879-020-05713-0
BMC Infectious Diseases; Wang R, Zhang D et. al.

Jan 13th, 2021 - Hepatitis B virus (HBV) infection is a high-risk factor of hepatocellular carcinoma (HCC). Cellular immune responses are essential for HCC development, and the CD4+ and CD8+ T subtypes are identified as the primary anti-tumor immune cells. In the ...

Cytokine profile during occult hepatitis B virus infection in chronic hepatitis C patie...
https://doi.org/10.1186/s12985-021-01487-2 10.1007/s00281-012-0327-7 10.1016/j.jhep.2019.03.034 10.1186/s12882-015-0010-z 10.1002/jmv.21121 10.1016/S1473-3099(02)00345-6 10.1111/liv.12324 10.1055/s-0039-1678728 10.3748/wjg.v17.i15.1927 10.1128/CMR.00018-11 10.3349/ymj.2017.58.3.557 10.1016/S2468-1253(18)30002-5 10.1007/s00535-016-1273-2 10.1186/1743-422X-7-324 10.1016/j.jhep.2013.05.043 10.3748/wjg.v21.i42.11931 10.1006/viro.1999.9833 10.1016/S0168-8278(01)00264-1 10.1128/JVI.79.5.3038-3051.2005 10.1111/j.1440-1746.2011.06940.x 10.1016/j.patbio.2009.11.001 10.1111/j.1478-3231.2012.02764.x 10.1159/000329809 10.1038/cddis.2013.219 10.1038/cti.2016.68 10.4049/jimmunol.1103139 10.1016/j.jviromet.2018.03.001 10.1080/10635150600755453 10.1590/S0100-879X2006005000197 10.1590/S0004-28032007000100013 10.1111/hdi.12285 10.1111/j.1440-1746.2009.05972.x 10.1590/S0100-879X2006000400013 10.1111/j.1399-3062.2005.00091.x 10.1016/j.virusres.2017.09.022 10.1053/jhep.2001.28708 10.1016/S0140-6736(05)17961-6 10.3350/kjhep.2008.14.1.67 10.7150/jca.6609 10.1111/j.1478-3231.2011.02481.x 10.3748/wjg.v17.i12.1558 10.1002/1096-9071(200103)63:3<220::AID-JMV1004>3.0.CO;2-3 10.1002/(SICI)1096-9071(199907)58:3<201::AID-JMV3>3.0.CO;2-2 10.1016/S0168-8278(00)80311-6 10.1016/S0168-8278(00)00100-8 10.1111/j.1572-0241.2000.03371.x 10.1002/jmv.1057 10.1016/j.cyto.2009.06.005 10.1590/S0074-02762011000800018 10.1016/j.humimm.2014.08.198 10.3748/wjg.v12.i3.482 10.1016/j.cyto.2017.04.008 10.1098/rsob.190109 10.1016/j.autrev.2012.05.004 10.1002/hep.23273 10.1111/j.1537-2995.2012.03575.x 10.1111/imm.12720 10.1097/QAD.0000000000000654 10.1016/j.virol.2015.02.026 10.1146/annurev.immunol.17.1.701 10.4238/2014.November.27.2 10.1016/j.jhep.2011.11.011
Virology Journal; Ribeiro CRA, de Almeida NAA et. al.

Jan 13th, 2021 - The hepatitis B virus (HBV) is one of the leading causes of acute, chronic and occult hepatitis (OBI) representing a serious public health threat. Cytokines are known to be important chemical mediators that regulate the differentiation, proliferat...

Characteristics and etiologies of hepatocellular carcinoma in patients without cirrhosi...
https://doi.org/10.1371/journal.pone.0244939
PloS One; Yen YH, Cheng YF et. al.

Jan 13th, 2021 - A recent study from the United States reported that nearly 12% of hepatocellular carcinomas (HCCs) occurred in patients without cirrhosis. Non-alcoholic fatty liver disease (NAFLD) was the most common liver disease in these patients. We aim to eva...

see more →

News  391 results

USPSTF Reaffirms Advice on HBV Screening in High-Risk Individuals
https://www.medscape.com/viewarticle/942681

Dec 15th, 2020 - NEW YORK (Reuters Health) - The U.S. Preventive Services Task Force (USPSTF) continues to recommend screening for hepatitis B virus (HBV) in nonpregnant adolescents and adults at increased risk for HBV infection, concluding with "moderate certaint...

Serum Hep B Virus RNA Levels Useful When Deciding When to Stop Treatment
https://www.staging.medscape.com/viewarticle/936294

Aug 25th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...

Serum Hep B Virus RNA Levels Useful When Deciding When to Stop Treatment
https://www.medscape.com/viewarticle/936294

Aug 25th, 2020 - NEW YORK (Reuters Health) - Patients with chronic hepatitis B who have undetectable serum hepatitis B virus (HBV) RNA can safely undergo cessation of entecavir antiviral treatment, according to a new study. "Serum HBV RNA reflects an important int...

Renal Dysfunction Improves Following Switch From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide
https://www.medscape.com/viewarticle/935890

Aug 18th, 2020 - NEW YORK (Reuters Health) - In HIV/hepatitis B virus (HBV)-coinfected individuals with renal dysfunction, renal function improves after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF), according to results from a ...

Renal Dysfunction Improves Following Switch From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide
https://www.staging.medscape.com/viewarticle/935890

Aug 18th, 2020 - NEW YORK (Reuters Health) - In HIV/hepatitis B virus (HBV)-coinfected individuals with renal dysfunction, renal function improves after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF), according to results from a ...

see more →

Patient Education  3 results see all →